{{Drugbox
| IUPAC_name               = 1-benzyl-1-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)hydrazine
| image                    = Domoxin.svg
| CAS_number               = 61-74-5
| CAS_supplemental         = 
| ATC_prefix               = None
| ATC_suffix               = 
| ChEMBL = 2105038
| PubChem                  = 208853
| ChemSpiderID             = 180960
| C = 16 | H = 18 | N = 2 | O = 2
| molecular_weight         = 270.326 g/mol
| smiles                   = O1c3c(OC(C1)CN(N)Cc2ccccc2)cccc3
| StdInChI                 = 1S/C16H18N2O2/c17-18(10-13-6-2-1-3-7-13)11-14-12-19-15-8-4-5-9-16(15)20-14/h1-9,14H,10-12,17H2
| StdInChIKey              = IXTXYSAWZICAPV-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}

'''Domoxin''' ([[International Nonproprietary Name|INN]]) is a [[hydrazine]] derivative [[monoamine oxidase inhibitor]] (MAOI) [[antidepressant]] which was never marketed.<ref name="WHO2011">{{cite web | url = http://www.who.int/medicines/services/inn/StemBook_2011_Final.pdf | author = [[World Health Organization]] | title = The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances | year = 2011 | format = PDF | accessdate = 2012-05-20}}</ref>

== See also ==
* [[Monoamine oxidase inhibitor]]
* [[Hydrazine (antidepressant)]]

== References ==
{{Reflist}}

{{Antidepressants}}
{{Navboxes
| title = [[Monoamine]]rgics
| state = collapsed
| list1  = {{Adrenergics}} {{Dopaminergics}} {{Melatonergics}} {{Serotonergics}}
}}

[[Category:Antidepressants]]
[[Category:Benzodioxins]]
[[Category:Hydrazines]]
[[Category:Monoamine oxidase inhibitors]]


{{nervous-system-drug-stub}}